See more : Taiwan Puritic Corp. (6826.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Delivra Health Brands Inc. (DHBUF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Delivra Health Brands Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- PT Bank Negara Indonesia (Persero) Tbk (PTBRY) Income Statement Analysis – Financial Results
- Landmark Cars Limited (LANDMARK.BO) Income Statement Analysis – Financial Results
- Captain Pipes Limited (CAPPIPES.BO) Income Statement Analysis – Financial Results
- UniCredit S.p.A. (UCG.MI) Income Statement Analysis – Financial Results
- Freehold Royalties Ltd. (FRHLF) Income Statement Analysis – Financial Results
Delivra Health Brands Inc. (DHBUF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://delivrahealthbrands.com
About Delivra Health Brands Inc.
Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It is involved in selling of cannabis, liquid sleep shots, sleep powder packets, and pain relief creams. The company is headquartered in Vancouver, Canada.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.38M | 9.79M | 8.14M | 7.96M | 8.38M | 11.47M | 725.98K | 75.95K | 246.70K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 5.98M | 4.97M | 5.54M | 6.04M | 9.02M | 8.46M | -197.84K | -176.42K | 1.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 6.40M | 4.82M | 2.60M | 1.92M | -631.00K | 3.01M | 923.82K | 252.37K | -951.13K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 51.70% | 49.26% | 31.99% | 24.12% | -7.53% | 26.24% | 127.25% | 332.29% | -385.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 352.00K | 72.00K | 179.00K | 100.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.25M | 4.08M | 4.89M | 7.89M | 14.20M | 18.23M | 10.67M | 7.03M | 46.25K | 45.97K | 36.51K | 39.67K | 45.88K | 32.86K | 54.67K |
| Selling & Marketing | 1.55M | 775.00K | 1.60M | 1.01M | 2.22M | 2.91M | 780.04K | 470.61K | 30.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.80M | 4.86M | 6.50M | 8.89M | 16.42M | 21.14M | 11.45M | 7.50M | 46.25K | 45.97K | 36.51K | 39.67K | 45.88K | 32.86K | 54.67K |
| Other Expenses | 1.31M | 1.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.11M | 6.19M | 8.62M | 11.18M | 19.09M | 21.74M | 11.52M | 8.60M | 46.25K | 45.97K | 36.51K | 39.67K | 45.88K | 32.86K | 54.67K |
| Cost & Expenses | 13.09M | 11.15M | 14.15M | 17.22M | 28.11M | 30.20M | 11.32M | 8.42M | 46.25K | 45.97K | 36.51K | 39.67K | 45.88K | 32.86K | 54.67K |
| Interest Income | 0.00 | 250.00K | 635.00K | 41.00K | 318.00K | 140.00K | 14.50K | 24.97K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 169.00K | 250.00K | 635.00K | 0.00 | 804.00K | 45.00K | 1.90M | 149.39K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.31M | 1.33M | 2.12M | 2.22M | 2.34M | 879.00K | 456.79K | 1.10M | 26.96K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 2.35M | -33.00K | -4.26M | -7.04M | -54.86M | -25.33M | -10.13M | -7.19M | -2.73M | -45.97K | -36.51K | -39.67K | -45.88K | -32.86K | -54.67K |
| EBITDA Ratio | 19.02% | -0.34% | -47.83% | 86.11% | -200.91% | -156.39% | -1,394.95% | -9,515.74% | -18.75% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -710.00K | -1.36M | -6.01M | -21.96M | -61.26M | -28.14M | -10.60M | -6.15M | -46.25K | -45.97K | -36.51K | -39.67K | -45.88K | -32.86K | -54.67K |
| Operating Income Ratio | -5.74% | -13.92% | -73.87% | -276.01% | -730.70% | -245.41% | -1,459.87% | -8,093.49% | -18.75% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.59M | 1.18M | -599.00K | -15.63M | -1.50M | 73.00K | -2.01M | -2.29M | -512.30K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 876.00K | -184.00K | -7.01M | -22.67M | -62.77M | -27.97M | -12.61M | -8.44M | -46.25K | -45.97K | -36.51K | -39.67K | -45.88K | 0.00 | 0.00 |
| Income Before Tax Ratio | 7.08% | -1.88% | -86.12% | -284.97% | -748.70% | -243.92% | -1,736.52% | -11,110.24% | -18.75% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 250.00K | 635.00K | 19.28M | 17.70M | -285.00K | 1.90M | 149.39K | -26.97K | 0.00 | 0.00 | 0.00 | 45.88K | 32.86K | 54.67K |
| Net Income | 876.00K | -184.00K | -7.01M | -28.54M | -79.86M | -27.85M | -12.61M | -8.44M | -46.25K | -45.97K | -36.51K | -39.67K | -45.88K | -32.86K | -54.67K |
| Net Income Ratio | 7.08% | -1.88% | -86.12% | -358.70% | -952.49% | -242.93% | -1,736.52% | -11,110.24% | -18.75% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | -0.03 | -0.13 | -0.37 | -0.15 | -0.11 | -0.16 | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.33 |
| EPS Diluted | 0.00 | 0.00 | -0.03 | -0.13 | -0.37 | -0.15 | -0.11 | -0.16 | -0.02 | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 | -0.33 |
| Weighted Avg Shares Out | 285.71M | 252.62M | 252.62M | 225.96M | 214.64M | 179.77M | 120.06M | 53.80M | 2.29M | 1.75M | 1.73M | 1.91M | 2.29M | 2.14M | 168.21K |
| Weighted Avg Shares Out (Dil) | 285.66M | 252.62M | 252.62M | 225.96M | 214.64M | 179.77M | 120.06M | 53.80M | 2.29M | 1.75M | 1.73M | 1.91M | 2.29M | 2.14M | 168.21K |
Delivra Health Brands and its Leading Brands Dream Water (R) and LivRelief(TM) Report Financial Results for First Quarter of Fiscal 2025
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company in the health and wellness sector, is pleased to announce its financial and...
Delivra Health Brands delivers strong year-end results - ICYMI
Delivra Health Brands Inc. (TSX-V:DHB) this week reported strong year-end and quarterly results. CEO Gord Davey joined Proactive to talk through the results, highlighting a 26% increase in net revenue and the positive impact this growth has on the company's profitability.
Delivra Health Brands reports strong results for fiscal 2024
Delivra Health Brands Inc. (TSX-V:DHB) reported financial gains for the fiscal 2024 year, including a 26% year-over-year increase in net revenue. Revenue for the 12 months ended June 30, 2024, was $12.38 million, driven by strong sales in the US...
Delivra Health Brands Reports Continued Growth with Positive Adjusted EBITDA(1) and Improved Financial Results for FY2024
Delivra is a unique consumer packaged goods company strategically positioned in the health and wellness sector that provides high-quality brands to the global marketplace Continued net revenue growth of 26% year over year despite challenging business environments Increased gross profit...
Delivra Health Brands to Hold Conference Call to Discuss Results for the Year Ending June 30, 2024
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods leader uniquely positioned in the health and wellness sector, is pleased to announce it...
Delivra Health Brands expands with new markets and products - ICYMI
Delivra Health Brands Inc. (TSX-V:DHB) CEO Gord Davey sat down with Proactive to discuss the company's latest expansion efforts and updates to its health and wellness products. Davey also highlighted that innovation remains a key focus, with new products such...
Delivra Health CEO discusses Dream Water's expansion into the UAE - ICYMI
Delivra Health Brands Inc. (TSX-V:DHB) is expanding its reach in the Middle East, working with its partner in the region to bring its Dream Water product to pharmacies across the United Arab Emirates. In a recent interview with Proactive,...
Delivra Health Brands Announces Grant of Incentive Stock Options
Vancouver, British Columbia--(Newsfile Corp. - May 28, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that...
Delivra Health Brands grows revenue and profits year-to-date
Delivra Health Brands Inc. (TSX-V:DHB) is seeing growth in revenue, profit, and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in the fiscal year to date. For the nine-month period that ended March 31, 2024, the health and wellness...
Delivra Health and its Brands Dream Water TM and LivRelief TM Report Positive Adjusted EBITDA(1) for Third Quarter of Fiscal 2024
Vancouver, British Columbia--(Newsfile Corp. - May 15, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce its...
Source: https://incomestatements.info
Category: Stock Reports